These new, adaptive stem cells can lie dormant until needed, a new animal study using human cells shows.
A new type of stem cell – that is, a cell with regenerative abilities – could be closer on the horizon, a new study led by UNSW Sydney shows.
One common symptom of multiple sclerosis (MS) is vision impairment, and it can progress to blindness in some cases. Now, researchers at the University of California, Riverside (UCR) report a drug that was able to reverse that vision loss in mice.
Microfluidic device sheds light on how short-chain fatty acids produced by gut bacteria may influence neurological diseases.
MIT study sheds light on the longstanding question of why cancer cells get their energy from fermentation.
In the 1920s, German chemist Otto Warburg discovered that cancer cells don’t metabolize sugar the same way that healthy cells usually do. Since then, scientists have tried to figure out why cancer cells use this alternative pathway, which is much less efficient.
MIT biologists have now found a possible answer to this longstanding question. In a study appearing in Molecular Cell, they showed that this metabolic pathway, known as fermentation, helps cells to regenerate large quantities of a molecule called NAD+, which they need to synthesize DNA and other important molecules. Their findings also account for why other types of rapidly proliferating cells, such as immune cells, switch over to fermentation.
A mitochondrial hormone expressed by cells deep in the brain appears to play a role in improving metabolism and fighting off obesity, according to a new study in mice.
Formic ventures — taking on huge challenges — from virtual reality technologist to longevity biotechnology investor.
Michael Antonov is the Founder and CEO of The Michael Antonov Foundation (https://antonovfoundation.org/), a charitable organization that supports biotechnology research and various causes that improve well being of people around the world, as well as Formic Ventures (https://formic.vc/index.html), an early stage high tech and biotech investment firm focused on prolonging human healthspan and empowering human creativity.
Senior citizens are accustomed to constant probes by doctors, but wireless AI tech is enabling massive-scale, nonintrusive data monitoring.
This is a potential game changer in medicine.
Over the past two decades, gene therapy has come of age, but there are different means of delivering genetic payload.
Cells in a lab. But very good news.
Researchers from the Reik lab at the Babraham Institute have used the four Yamanaka reprogramming factors (OSKM) in order to epigenetically rejuvenate cells by 30 years, according to one epigenetic clock. […]
This is the THIRD PART of the interview with Harold Katcher in Modern Healthspan YouTube channel.
Dr. Harold Katcher is a professor of Biology at the University of Maryland. He has been a pioneer in the field of cancer research, in the development of modern aspects of gene hunting and sequencing. He carries expertise in bioinformatics, chronobiology, and biotechnology. Dr. Katcher is currently working in the capacity of Chief Technical Officer at Nugenics Research exploring rejuvenation treatments in mammals.
In May 2020 there was a paper published on biorxiv about the rejuvenation of rats by over 50%. We did a review of the paper which you can find linked to above. In this interview series we talk with Dr. Harold Katcher, one of the main authors of the paper about the experiment, the steps to get validation, commercialization and how the results fit into his theories of aging.
